Calendar Imunon, Inc.

Equities

IMNN

US15117N6022

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets 04:00:00 2025-01-17 pm EST			5-day change	1st Jan Change
0.9131 ^USD	+1.68%		+1.47%	-3.88%

Dec. 19	IMUNON, Inc. Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer	CI
Dec. 10	Imunon Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 Ovation 2 Study of Imnn-001	CI

Chart calendar Imunon, Inc.

dcc95a073f9374a6e28ac6b9.V3bgl0t6jq40JmKY-UpjJqlpDGFW6B9Knk0s9CRjxvQ.BDSKwywQ7fcHfxP8vjxRV8RYfygRj0wB9SRKkxwAo78SW6jifyD67EFxOw~e5097ae04bf086c78e492e63d7274001

Upcoming events on Imunon, Inc.

2025-03-26	Q4 2024 Earnings Release (Projected)
2025-05-18	Q1 2025 Earnings Release (Projected)
2025-08-12	Q2 2025 Earnings Release (Projected)
2025-11-16	Q3 2025 Earnings Release (Projected)

Past events on Imunon, Inc.

2024-11-08 06:30 pm	Society for Immunotherapy of Cancer Meeting - Abstract No: 9299
2024-11-08 01:15 pm	Society for Immunotherapy of Cancer Meeting - Abstract No: 9299
2024-11-07 11:00 am	Q3 2024 Earnings Call
2024-11-07 08:05 am	Q3 2024 Earnings Release
2024-09-18 10:00 am	R&D Day
2024-08-14 11:00 am	Q2 2024 Earnings Call
2024-08-14 08:00 am	Q2 2024 Earnings Release
2024-07-30 08:30 am	IMNN-001 Phase 2 OVATION 2 Study Results Call
2024-06-11	Annual General Meeting
2024-06-03 10:00 am	American Society of Clinical Oncology Meeting - Abstract No. TPS5633
2024-05-13 11:00 am	Q1 2024 Earnings Call
2024-05-13 08:00 am	Q1 2024 Earnings Release
2024-03-28 10:00 am	Q4 2023 Earnings Call
2024-03-28 08:00 am	Q4 2023 Earnings Release
2023-11-14 10:00 am	Q3 2023 Earnings Call
2023-11-14 08:00 am	Q3 2023 Earnings Release
2023-10-23 02:00 pm	Edition of International Vaccines Congress
2023-09-14 04:00 pm	R&D Day
2023-09-11 07:00 am	H.C. Wainwright Global Investment Conference
2023-08-10 11:00 am	Q2 2023 Earnings Call

Annual results

Fiscal Period	December	2021	2022	2023	2024	2025	2026
Net sales Million USD	Released Forecast Spread	0,50 0,50 0%	0,50 0,50 0%	0,00 0,00 -	0,00	0,00	0,00
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00	0,00	0,00
EBIT Million USD	Released Forecast Spread	-21,0 -21,1 0.4%	-24,9 -24,4 -1.98%	-21,0 -20,7 -1.62%	-20,7	-27,4	-36,5
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-22,2 -22,2 0.14%	-37,5 -28,9 -29.6%	-20,8 -20,2 -3.17%	-20,5	-27,4	-36,9
Net income Million USD	Released Forecast Spread	-20,8 -22,2 6.38%	-35,9 -28,6 -25.48%	-19,5 -20,2 3.18%	-20,5	-27,4	-36,9
EPS USD	Released Forecast Spread	-3,83 -4,05 5.43%	-5,03 -4,19 -20.19%	-2,16 -2,23 3.28%	-1,70	-1,04	-0,73
Announcement Date		31/03/22	30/03/23	28/03/24	-

Quarterly results

Fiscal Period	September	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00	0,00	0,00	0,00	0,00
EBIT Million USD	Released Forecast Spread	-5,68 -6,30 9.78%	-5,47 -6,27 12.73%	-3,90 -6,05 35.51%	-5,97 -5,61 -6.42%	-5,01 -5,36 6.49%	-5,01 -5,20 3.64%	-4,96 -5,90 15.92%	-3,94	-5,38	-4,92	-4,71	-4,90
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-5,59 -6,30 11.25%	-5,56 -6,28 11.47%	-3,48 -6,13 43.25%	-6,17 -5,55 -11.18%	-4,93 -5,43 9.15%	-4,79 -5,34 10.28%	-4,85 -5,98 18.91%	-5,90	-5,35	-4,90	-4,68	-4,87
Net income Million USD	Released Forecast Spread	-5,59 -6,30 11.25%	-5,56 -6,28 11.47%	-3,48 -6,13 43.25%	-4,89 -5,55 11.9%	-4,93 -5,43 9.15%	-4,79 -5,34 10.28%	-4,85 -5,98 18.91%	-5,90	-5,35	-4,90	-4,68	-4,87
EPS USD	Released Forecast Spread	-0,68 -0,69 1.45%	-0,61 -0,73 16.82%	-0,37 -0,66 43.94%	-0,52 -0,59 11.36%	-0,52 -0,57 8.24%	-0,51 -0,55 7.27%	-0,34 -0,40 15.53%	-0,37	-0,33	-0,30	-0,29	-0,30
Announcement Date		11/05/23	10/08/23	14/11/23	28/03/24	13/05/24	14/08/24	07/11/24	-	-	-	-	-

Upcoming sector events for Imunon, Inc.

2025-01-22	ABL BIO INC.: Q4 2024 Earnings Release
2025-01-29	BIOCON LIMITED: Q3 2025 Earnings Release
2025-02-04 06:30 am	REGENERON PHARMACEUTICALS, INC.: Q4 2024 Earnings Release
2025-02-04	VIKING THERAPEUTICS, INC.: Q4 2024 Earnings Release (Projected)
2025-02-04	ARROWHEAD PHARMACEUTICALS, INC.: Q1 2025 Earnings Release (Projected)
2025-02-05	ANAVEX LIFE SCIENCES CORP.: Q1 2025 Earnings Release (Projected)
2025-02-10	NEUROCRINE BIOSCIENCES, INC.: Q4 2024 Earnings Release (Projected)
2025-02-10	VERTEX PHARMACEUTICALS INCORPORATED: Q4 2024 Earnings Release (Projected)
2025-02-10	EXELIXIS, INC.: Q4 2024 Earnings Release
2025-02-11	NURIX THERAPEUTICS, INC.: Q4 2024 Earnings Release (Projected)

More events

Past sector events for Imunon, Inc.

2025-01-10 02:53 am	LUMOSA THERAPEUTICS CO., LTD.: December 2024 Sales and Revenue Release
2025-01-04 10:28 pm	PHARMAESSENTIA CORPORATION: December 2024 Sales and Revenue Release
2024-12-23 07:30 am	ANAVEX LIFE SCIENCES CORP.: Q4 2024 Earnings Release
2024-12-09 06:16 am	LUMOSA THERAPEUTICS CO., LTD.: November 2024 Sales and Revenue Release
2024-12-05 04:03 am	PHARMAESSENTIA CORPORATION: November 2024 Sales and Revenue Release
2024-11-26 04:00 pm	ARROWHEAD PHARMACEUTICALS, INC.: Q4 2024 Earnings Release
2024-11-18 07:00 am	IMMATICS N.V.: Q3 2024 Earnings Release
2024-11-14 04:01 pm	CELCUITY INC.: Q3 2024 Earnings Release
2024-11-14 04:01 pm	ASCENDIS PHARMA A/S: Q3 2024 Earnings Release
2024-11-14 08:00 am	ANNEXON, INC.: Q3 2024 Earnings Release